4.7 Article

Proteasomal inhibitors induce myeloma cell pyroptosis via the BAX/GSDME pathway

期刊

ACTA PHARMACOLOGICA SINICA
卷 44, 期 7, 页码 1464-1474

出版社

NATURE PUBL GROUP
DOI: 10.1038/s41401-023-01060-3

关键词

proteasome; multiple myeloma; GSDME; mitochondria; BAX

向作者/读者索取更多资源

In this study, it was found that proteasomal inhibitors (PIs) induce a novel type of cell death called pyroptosis in multiple myeloma (MM) through the GSDME pathway. The mitochondrial BAX/GSDME pathway was identified as the mechanism through which PIs trigger pyroptosis in MM cells. Combined treatment with Bcl-2 and proteasome inhibitors can increase therapeutic efficiency through induction of pyroptosis in MM cells.
Proteasomes are overexpressed in multiple myeloma (MM) and proteasomal inhibitors (PIs) have been widely used for the treatment of MM. PIs are reported to induce MM cell apoptosis but impair necroptosis. In the present study, we found that PIs MG132 and bortezomib induce MM cell pyroptosis, a novel type of cell death, in a GSDME-dependent manner. Lack of GSDME totally blocks PI-induced pyroptosis. Interestingly, we found that Caspase-3/6/7/9 are all involved in pyroptosis triggered by PIs because the specific inhibitor of each caspase ablates GSDME activation. PIs markedly reduce mitochondrial membrane potential. Moreover, PIs disrupt the interaction of Bcl-2 and BAX, induce cytochrome c release from mitochondria to cytosol and activate GSDME. Furthermore, we found that overexpression of an N-terminal portion of GSDME suffices to release cytochrome c from mitochondria and to activate Caspase-3/9, suggesting N-GSDME might penetrate the mitochondrial membrane. Consistent with Bcl-2 inhibition, BAX can induce MM cell pyroptosis in a GSDME-dependent manner. In accordance with these findings, inhibition of Bcl-2 synergizes with PIs to induce MM cell pyroptosis. Therefore, the present study indicates that PIs trigger MM cell pyroptosis via the mitochondrial BAX/GSDME pathway and provides a rationale for combined treatment of MM with Bcl-2 and proteasome inhibitors to increase therapeutic efficiency via induction of pyroptosis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据